When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VTGN - VistaGen on go with mid-stage study of AV-101 in Parkinson's; shares up 8%
VistaGen Therapeutics Inc.
Nano cap VistaGen Therapeutics (VTGN+7.7%) is up on increased volume in reaction to its announcement that the FDA has signed off on its IND for a Phase 2 clinical trial evaluating NMDA glutamate receptor modulator AV-101 for the potential treatment of dyskinesia (uncontrolled muscle movements) in Parkinson's disease (PD) patients.
More news on: VistaGen Therapeutics, Inc., Healthcare stocks news, Stocks on the move,